-
Mashup Score: 1Stinting on care, paying less - 6 month(s) ago
Medicare Advantage insurers pay less than traditional Medicare. More providers are crying, “No mas.”
Source: gooznews.substack.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1How a Lucrative Surgery Took Off Online and Disfigured Patients - 6 month(s) ago
More surgeons are opting for a complicated hernia repair that they learned from videos on social media showing shoddy techniques.
Source: www.nytimes.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1How a Lucrative Surgery Took Off Online and Disfigured Patients - 6 month(s) ago
More surgeons are opting for a complicated hernia repair that they learned from videos on social media showing shoddy techniques.
Source: www.nytimes.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0The care was crucial. The insurer was reputable. The bill?$155,493. - 6 month(s) ago
One Woodbury man’s story shows how patients can get stuck in the middle when insurers and hospitals fight over coverage details.
Source: www.startribune.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 9Don't Give Symptom-Free People Alzheimer's Drugs - 7 month(s) ago
Some people advocate giving Alzheimer’s disease drugs to people with normal cognitive function who have elevated amyloid levels in their brains. This is not only wrong, but dangerous.
Source: www.thehastingscenter.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Tell Me How I Should Feel About This Study - 10 month(s) ago
Evidence is what separates doctors from palm readers. But the evidence has to be trustworthy
Source: johnmandrola.substack.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Digital Exhaust #197 - 10 month(s) ago
Why body scans and AI generated commercials are a mistake
Source: 33charts.substack.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Experimental Alzheimer's drug slows cognitive declines in large trial, drugmaker Eli Lilly says | CNN - 1 year(s) ago
An experimental Alzheimer’s medication slowed declines in patients’ ability to think clearly and perform daily tasks by more than a third in a large clinical trial, drugmaker Eli Lilly said Wednesday.
Source: CNNCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.
Source: www.nytimes.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Casey has left us - 1 year(s) ago
A CaringBridge website is a personal health journal, rallying friends and family during any type of health journey. Start a free CaringBridge website today.
Source: CaringBridgeCategories: Healthcare Professionals, Latest HeadlinesTweet
.@_GoozNews says many are jumping off the Medicare Advantage train. Seniors, hospital systems and affiliated physician practices have seen enough. https://t.co/5oXFrQDkVD